Quoin Pharmaceuticals, Ltd. reported that on August 21, 2025, shareholders approved several proposals, including increasing authorized shares from 100 million to 5 billion and appointing Sally Lawlor as the new CFO with a €380,000 salary. The sentiment is neutral, and this is a significant event for the company.